Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Marble Biomaterials is a biotechnology company specializing in the production of sustainable, bio-based specialty chemicals for the food, fragrance, and personal care industries. The company utilizes proprietary fermentation and extraction technologies to convert organic biomass into high-value natural compounds, such as esters and carboxylic acids, which serve as drop-in replacements for petroleum-derived ingredients. Their approach emphasizes non-GMO processes and circular economy principles by upcycling side-stream waste from other industries. In 2018, Blue Marble was acquired by Socati Corp to leverage its expertise in complex botanical extractions and molecular separation for the cannabinoid market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Marble Biomaterials.